|
|
Douglas Hanahan, Gabriele Bergers, Emily Bergsland
J Clin Invest. 2000;
105(8):1045
doi:10.1172/JCI9872
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(147)
| Title and authors |
Publication |
Year |
Handbook of Clinical Neurology
Andrew S. Chi, Patrick Y. Wen
|
Neuro-Oncology Vol 104 HCN Series
|
2012 |
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab
Filippo Pietrantonio, Pamela Biondani, Alessandro Pellegrinelli, Alfonso Marchianò, Katia Fiorella Dotti, Roberto Buzzoni, Maria Di Bartolomeo
|
Med Oncol
|
2012 |
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy :
Manuela Miscoria, Fabrizio Tonetto, Laura Deroma, Piernicola Machin, Carla Di Loreto, Pamela Driol, Alessandro Marco Minisini, Stefania Russo, Claudia Andreetta, Mauro Mansutti
|
Anti-Cancer Drugs
|
2012 |
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: Synergy or antagonism?
Amr S. Abu Lila, Tomoko Okada, Yusuke Doi, Masako Ichihara, Tatsuhiro Ishida, Hiroshi Kiwada
|
International Journal of Pharmaceutics
|
2012 |
Multifunctional Nanocomposites for Biomedical Applications
Seungjoo Haam, Kwangyeol Lee, Jaemoon Yang, Yong-Min Huh
|
Nanotechnologies for the Life Sciences Online
|
2012 |
Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
Hyun Young Woo, Jun Mo Youn, Si Hyun Bae, Jeong Won Jang, Jung Hoon Cha, Hye Lim Kim, Ho Jong Chun, Byung Gil Choi, Jong Young Choi, Seoung Kew Yoon
|
Korean J Hepatol
|
2012 |
Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?
Nicolas André, Laetitia Padovani, Eddy Pasquier
|
Future Oncology
|
2011 |
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.
Maite Verreault, Dita Strutt, Dana Masin, Malathi Anantha, Andrew Yung, Piotr Kozlowski, Dawn Waterhouse, Marcel B Bally, Donald T Yapp
|
BMC Cancer
|
2011 |
Dose-Dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer
Robert L. Coleman
|
Clinical Ovarian Cancer
|
2011 |
Exploring and challenging the network of angiogenesis
Raúl Montañez, Francisca Sánchez-Jiménez, Ana R. Quesada, Miguel Ángel Medina
|
Sci. Rep.
|
2011 |
|
